- Home
- NA vs LUMO Comparison
NA vs LUMO Comparison
Compare NA & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NA
- LUMO
- Stock Information
- Founded
- NA 2019
- LUMO 2011
- Country
- NA China
- LUMO United States
- Employees
- NA N/A
- LUMO N/A
- Industry
- NA Semiconductors
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- NA Technology
- LUMO Health Care
- Exchange
- NA Nasdaq
- LUMO Nasdaq
- Market Cap
- NA 32.3M
- LUMO 37.4M
- IPO Year
- NA 2022
- LUMO N/A
- Fundamental
- Price
- NA $8.76
- LUMO $4.34
- Analyst Decision
- NA
- LUMO Buy
- Analyst Count
- NA 0
- LUMO 4
- Target Price
- NA N/A
- LUMO $9.38
- AVG Volume (30 Days)
- NA 240.6K
- LUMO 133.0K
- Earning Date
- NA 09-18-2024
- LUMO 11-07-2024
- Dividend Yield
- NA N/A
- LUMO N/A
- EPS Growth
- NA N/A
- LUMO N/A
- EPS
- NA N/A
- LUMO N/A
- Revenue
- NA $6,991,446.00
- LUMO $2,205,000.00
- Revenue This Year
- NA N/A
- LUMO $184.11
- Revenue Next Year
- NA N/A
- LUMO N/A
- P/E Ratio
- NA N/A
- LUMO N/A
- Revenue Growth
- NA N/A
- LUMO 26.94
- 52 Week Low
- NA $2.75
- LUMO $1.37
- 52 Week High
- NA $47.50
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- NA 52.67
- LUMO 4.26
- Support Level
- NA $6.67
- LUMO $4.31
- Resistance Level
- NA $10.42
- LUMO $4.39
- Average True Range (ATR)
- NA 1.94
- LUMO 0.03
- MACD
- NA -0.18
- LUMO -0.44
- Stochastic Oscillator
- NA 29.07
- LUMO 0.00
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.